|
US2020009119A1
|
|
Methods and Compositions to Inhibit Symptoms Associated with Veisalgia
|
|
WO2019178516A1
|
|
Methods and compositions to treat enteropathic arthritis
|
|
WO2019055942A1
|
|
Methods and compositions to inhibit tolerance to opioids
|
|
AU2018333954A1
|
|
Methods and compositions to inhibit dependence on opioids
|
|
AU2018333952A1
|
|
Methods and compositions to inhibit symptoms associated with opioid withdrawal
|
|
US2019060297A1
|
|
Methods and compositions to inhibit adverse effects associated with vaccinations
|
|
WO2018232260A1
|
|
Methods and compositions to inhibit symptoms associated with viral upper respiratory tract infections
|
